Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Fighting Drug-Resistant Flu Viruses
Amid reports that swine flu viruses are developing the ability to shrug off existing antiviral drugs, scientists in Japan are reporting a first-of-its kind discovery that could foster a new genre of antivirals that sidestep resistance problems, according to an article scheduled for the July 23 issue of the ACS" Journal of the Medicinal Chemistry, a bi-weekly publication.
generic viagra online
Human Genome Sciences Submits Biologics License Application To FDA For ABthrax(TM)
Human Genome Sciences, Inc. (Nasdaq: HGSI) announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for its human monoclonal antibody drug ABthrax(TM) (raxibacumab) for the treatment of inhalation anthrax.
News of the day
Needle Exchange Program In Humboldt County, Calif., Forced To End; Officials Hoping For Federal Help
Health officials in Humboldt County, Calif., "will be watching closely" the debate expected to ensue over legislation introduced last week containing "a provision that would scrap the federal funding ban on needle exchange programs that has been in place for years," the Eureka Times-Standard reports. According to the Times-Standard, "This month, Open Door Community Health Centers" clinics in Arcata and Eureka quietly stopped administering the needle exchange program they have operated for almost a decade." Open Door Community Health Centers Chief Operating Officer Cheyenne Spetzler, said, "The footprint of the program just kept getting bigger." In addition, grant funding was often limited to covering the costs of the needles and not the costs of administering the programs, Spetzler said. County Department of Health and Human Services Programs Director Barbara LaHaie said the county is currently seeking alternatives to continue the program. However, "Without a reliable funding stream, that may prove difficult," the article states (Greenson, 7/13).
Health Insurance

The Role Of Genetic Factors In Adult ADHD

22nd Congress of the European College of Neuropsychopharmacology (ECNP), 12 - 16 September 2009, Istanbul, Turkey Dr. Barbara Franke, who is coordinating the International Multicentre persistent ADHD CollaboraTion (IMpACT) will present the latest findings in the identification of risk genes for ADHD. She will explain how the findings of IMpACT may help to define targets for the development of new and more effective treatments for ADHD, and also contribute to early disease prevention. Attention deficit/hyperactivity disorder, or ADHD, is one of the most common neuropsychiatric disorders of childhood. Worldwide, 3 - 12% of children are affected with the disorder, whose symptoms include age-inappropriate hyperactive and impulsive behaviour and/or a reduced ability to focus attention. ADHD has classically been viewed as a disorder of children, but the majority of patients carries ADHD symptoms, or even the full ADHD-diagnosis, into adulthood. This leads to social and professional problems and is associated with considerable costs. Converging evidence suggests that ADHD aetiology has a robust genetic component. The heritability of the adult form of ADHD appears even higher than that of children. With the adult form of ADHD being the most severe one, focusing on the genetics of ADHD in adults can be expected to guide future research in this challenging field. For that reason, a group of researchers focusing on the genetics of adult ADHD decided to pool their efforts in the International Multicentre persistent ADHD CollaboraTion (IMpACT), investigating the largest clinical ADHD sample worldwide. Dr. Barbara Franke, Ph.D., who is coordinating this promising research project, will present the latest findings in the identification of risk genes for ADHD. She will explain how the findings of IMpACT may help to define targets for the development of new and more effective treatments for ADHD, and also contribute to early disease prevention. European College of Neuropsychopharmacology


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009